Acceleron Pharma Inc (XLRN) Return on Assets ROA from the third quarter of 2021 to third quarter of 2020 and for the year 2021, Average High and Low, Fundamental Ratios from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acceleron Pharma inc  (NASDAQ: XLRN)


Acceleron Pharma Inc's ROA from the third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Acceleron Pharma Inc's ROA in the third quarter of 2021?
Acceleron Pharma Inc recorded a cumulative net loss of $-255 million during 12 months ending in the third quarter of 2021, resulting in a negative return on assets (ROA) of -30.26%.

However, within the Healthcare sector 508 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2021 from 4002 to 4065.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Total Assets Change -16.83 % 77.69 % 84.56 % 90.73 % 93.51 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -255 -224 -179 -166 -132
Return On Assets (TTM) -30.26 % -25.38 % -22.56 % -23.94 % -22.64 %
XLRN's Total Ranking # 4065 # 4002 # 3830 # 4239 # 3692
Total Assets (TTM) in million 771 820 857 922 927
Seq. Total Assets Change -5.92 % -4.33 % -7.05 % -0.58 % 100.99 %
Seq. Net Income Change - - - - -

XLRN's 5 Years Annual ROA >> Back to XLRN Management Effectiveness >> Compare XLRN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 65
Sector # 509
Overall # 3953

Return On Assets Statistics
High Average Low
74.32 %
-21.27 %
-40.14 %
(Mar 31 2014)   (Jun 30 2017)





Financial Statements
Acceleron Pharma Inc's Assets $ 771 million XLRN's Balance sheet
Acceleron Pharma Inc's Income $ -70 million Quarterly XLRN's Income Statement
XLRN's Income by Division See XLRN's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
Y / Y Total Assets Change 80.75 % 60.74 % -19.29 % 57.15 % 69.23 %
Total Assets in million 913 505 314 389 248
Y / Y Net Income Change - - - - -
Net Income in million -166 -125 -119 -108 -57
Annual Return On Assets -18.19 % -24.73 % -37.84 % -27.87 % -23.02 %

XLRN's 5 Years Annual ROA >> Back to XLRN Management Effectiveness >> Compare XLRN ROA to its Competitors



More Return On Assets Ratios
XLRN's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
XLRN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for XLRN's Competitors
Subscribers only: Roa for Acceleron Pharma Inc's Suppliers
Subscribers only: Return On Assets for XLRN's Customers

You may also want to know
XLRN's Roi XLRN's Inventory Turnover Ratio XLRN's Growth Rates XLRN's Dividend Comparisons
XLRN's Profitability Ratios XLRN's Asset Turnover Ratio XLRN's Dividend Growth
XLRN's Roe XLRN's Valuation Ratios XLRN's Financial Strength Ratios XLRN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2021, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.